search
Back to results

The Box: Using Smart Technology to Improve One-year Outcome of Myocardial Infarction Patients (TheBox)

Primary Purpose

Myocardial Infarction

Status
Completed
Phase
Not Applicable
Locations
Netherlands
Study Type
Interventional
Intervention
The Box
Sponsored by
Leiden University Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Myocardial Infarction focused on measuring Myocardial infarction, e-Health, mHealth, mobile phones, smartphone, follow-up

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patient is admitted with acute myocardial infarction
  • Patient is able to communicate in English or Dutch at B1 level

Exclusion Criteria:

  • Body Mass Index > 35 kg x m-2
  • Included in another randomized controlled trial
  • Patient is <18 years of age
  • Patient is considered an incapacitated adult
  • Patient is pregnant
  • Patient is unwilling to sign the informed consent form

Sites / Locations

  • Leiden University Medical Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

The Box

Control

Arm Description

After randomization, patients in the intervention group will receive a box ("The Box") with all the devices described above. Instructions about the installation and usage of the devices will be given. Patients will be asked to measure their weight and blood pressure once a day. Furthermore, patients will be asked to record an ECG using the AliveCor once a day. Moreover, they are asked to record an ECG in case of any symptoms of possible cardiac origin, as judged by the patient. All data will be automatically transferred to the Leiden University Medical Center. Lastly, two of the four outpatient clinical visits will be done via a video connection. The content of the interview will be comparable to the content of a regular outpatient clinic visit.

Patients who are randomized to the control group will receive regular care.

Outcomes

Primary Outcome Measures

Controlled Blood pressure
A blood pressure is considered controlled if the average of three measurements is below 140 (systolic) and 90 (diastolic) after 12 months of follow-up

Secondary Outcome Measures

Patient satisfaction of received care
Patient satisfaction, defined as the hight of scores derived from validated patient satisfaction questionnaire, will be measured in both groups.
Major adverse cardiac events
Defined as cardiovascular death, recurrent STEMI, recurrent NST-ACS, revascularization, hospitalization for heart failure, TIA or ischaemic stroke
Medication-adherence
Medication adherence is measured by validated medication adherence questionnaires. This questionnaires asks if patients take their medicines in accordance to doctors advice.
Physical activity
Measured by the iPAQ questionnaire
Quality of life
Measured by the validated SF-36 questionnaire
Healthcare utilization
Defined as the number of hospital visits, defined as an outpatient clinic visit, emergency care visit or admission for any reason. This will be measured via questionnaires and verified by EMR data
Percentage of patients in which a previously unknown sustained arrhythmia (30 seconds or more) is detected

Full Information

First Posted
August 9, 2016
Last Updated
December 5, 2018
Sponsor
Leiden University Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT02976376
Brief Title
The Box: Using Smart Technology to Improve One-year Outcome of Myocardial Infarction Patients
Acronym
TheBox
Official Title
The Box: Using Smart Technology to Improve One-year Outcome of Myocardial Infarction Patients
Study Type
Interventional

2. Study Status

Record Verification Date
December 2018
Overall Recruitment Status
Completed
Study Start Date
May 12, 2016 (Actual)
Primary Completion Date
November 9, 2018 (Actual)
Study Completion Date
November 9, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Leiden University Medical Center

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Study to investigate whether a smart technology intervention can improve clinical and cost-effectiveness of one-year follow-up in patients who suffered from acute myocardial infarction.
Detailed Description
Rationale: Smart technology could improve quality of care in patients after acute myocardial infarction (AMI) with either ST or non-ST elevation. Objective: The objective of this study is to measure the effect of a smart technology intervention on patients after AMI. Study design: The design of the study is a single-center, open randomized-controlled trial. Study population: The study population consists of patients who have been discharged from the ward of the cardiology department of the Leiden University Medical Center after primary percutaneous coronary intervention (PCI) for either ST or non-ST elevation myocardial infarction. Intervention: Patients will be randomized to either "The Box" or regular follow-up. Patients who have been randomized to The Box will receive a box containing a smartphone compatible electrocardiogram (ECG) monitor, a weight scale, an activity tracker and a blood pressure monitor. If patients are randomized to The Box, two of the four outpatient clinic visits will be replaced by an e-consult, in which a patient does not have to go to the hospital, but talks with his or her doctor or nurse practitioner via a secured video connection. Main study parameters/endpoints: The primary endpoint of the study will be the percentage of patients with controlled blood pressure in both groups.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Myocardial Infarction
Keywords
Myocardial infarction, e-Health, mHealth, mobile phones, smartphone, follow-up

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
200 (Actual)

8. Arms, Groups, and Interventions

Arm Title
The Box
Arm Type
Experimental
Arm Description
After randomization, patients in the intervention group will receive a box ("The Box") with all the devices described above. Instructions about the installation and usage of the devices will be given. Patients will be asked to measure their weight and blood pressure once a day. Furthermore, patients will be asked to record an ECG using the AliveCor once a day. Moreover, they are asked to record an ECG in case of any symptoms of possible cardiac origin, as judged by the patient. All data will be automatically transferred to the Leiden University Medical Center. Lastly, two of the four outpatient clinical visits will be done via a video connection. The content of the interview will be comparable to the content of a regular outpatient clinic visit.
Arm Title
Control
Arm Type
No Intervention
Arm Description
Patients who are randomized to the control group will receive regular care.
Intervention Type
Other
Intervention Name(s)
The Box
Intervention Description
The Box contains four smartphone compatible devices. Patients will measure their vital signs and automatically send them to the hospital.
Primary Outcome Measure Information:
Title
Controlled Blood pressure
Description
A blood pressure is considered controlled if the average of three measurements is below 140 (systolic) and 90 (diastolic) after 12 months of follow-up
Time Frame
One year
Secondary Outcome Measure Information:
Title
Patient satisfaction of received care
Description
Patient satisfaction, defined as the hight of scores derived from validated patient satisfaction questionnaire, will be measured in both groups.
Time Frame
One year
Title
Major adverse cardiac events
Description
Defined as cardiovascular death, recurrent STEMI, recurrent NST-ACS, revascularization, hospitalization for heart failure, TIA or ischaemic stroke
Time Frame
One year
Title
Medication-adherence
Description
Medication adherence is measured by validated medication adherence questionnaires. This questionnaires asks if patients take their medicines in accordance to doctors advice.
Time Frame
One year
Title
Physical activity
Description
Measured by the iPAQ questionnaire
Time Frame
One year
Title
Quality of life
Description
Measured by the validated SF-36 questionnaire
Time Frame
One year
Title
Healthcare utilization
Description
Defined as the number of hospital visits, defined as an outpatient clinic visit, emergency care visit or admission for any reason. This will be measured via questionnaires and verified by EMR data
Time Frame
One year
Title
Percentage of patients in which a previously unknown sustained arrhythmia (30 seconds or more) is detected
Time Frame
One year

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patient is admitted with acute myocardial infarction Patient is able to communicate in English or Dutch at B1 level Exclusion Criteria: Body Mass Index > 35 kg x m-2 Included in another randomized controlled trial Patient is <18 years of age Patient is considered an incapacitated adult Patient is pregnant Patient is unwilling to sign the informed consent form
Facility Information:
Facility Name
Leiden University Medical Center
City
Leiden
State/Province
Zuid-Holland
ZIP/Postal Code
2333 ZA
Country
Netherlands

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
35468091
Citation
Treskes RW, van den Akker-van Marle ME, van Winden L, van Keulen N, van der Velde ET, Beeres S, Atsma D, Schalij MJ. The Box-eHealth in the Outpatient Clinic Follow-up of Patients With Acute Myocardial Infarction: Cost-Utility Analysis. J Med Internet Res. 2022 Apr 25;24(4):e30236. doi: 10.2196/30236.
Results Reference
derived
PubMed Identifier
32297946
Citation
Treskes RW, van Winden LAM, van Keulen N, van der Velde ET, Beeres SLMA, Atsma DE, Schalij MJ. Effect of Smartphone-Enabled Health Monitoring Devices vs Regular Follow-up on Blood Pressure Control Among Patients After Myocardial Infarction: A Randomized Clinical Trial. JAMA Netw Open. 2020 Apr 1;3(4):e202165. doi: 10.1001/jamanetworkopen.2020.2165.
Results Reference
derived
PubMed Identifier
28939546
Citation
Treskes RW, van Winden LA, van Keulen N, Atsma DE, van der Velde ET, van den Akker-van Marle E, Mertens B, Schalij MJ. Using Smart Technology to Improve Outcomes in Myocardial Infarction Patients: Rationale and Design of a Protocol for a Randomized Controlled Trial, The Box. JMIR Res Protoc. 2017 Sep 22;6(9):e186. doi: 10.2196/resprot.8038.
Results Reference
derived

Learn more about this trial

The Box: Using Smart Technology to Improve One-year Outcome of Myocardial Infarction Patients

We'll reach out to this number within 24 hrs